Company: BIAF
Filing Date: 2025-06-27
Form Type: POS AM
Source: 0001641172-25-016923
Chunk: 173

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-27
Form: POS AM
Chunk 173
---
 determining the accrued expenses balance in each reporting period. As actual costs become
known, the Company adjusts its accrued liabilities. The Company has not experienced any material differences between accrued costs and
actual costs incurred since its inception.

Regulatory Matters

Regulations imposed by federal, state,
and local authorities in the U.S. are a significant factor in providing medical care. In the U.S., drugs, biological products, and medical
devices are regulated by the Federal Food, Drug, and Cosmetic Act (“FDCA”), which is administered by the Food and Drug Administration
(“FDA”) and the CMS. The Company has not yet obtained marketing authorization from the FDA but is able to market its CyPathLung test as a laboratory developed test (“LDT”) sold by Precision Pathology Laboratory Services, a CAP-accredited,
CLIA-certified clinical pathology laboratory and wholly owned subsidiary.

Note 3. ACCOUNTS AND OTHER RECEIVABLES, NET

The
following is a summary of accounts receivables and other receivables:

SCHEDULE OF ACCOUNTS AND OTHER RECEIVABLES

|                                           |     |   | March 31, 2025 |     |   | December 31, 2024 |
|:------------------------------------------|:----|:--|---------------:|:----|:--|------------------:|
| Patient service fees                      |     | $ |        744,859 |     | $ |           915,488 |
| Histology service fees                    |     |   |        189,904 |     |   |           190,648 |
| Medical director fees                     |     |   |         11,600 |     |   |             5,194 |
| Other receivables                         |     |   |         17,381 |     |   |            27,874 |
| Total accounts and other receivables, net |     | $ |        963,744 |     | $ |         1,139,204 |

Note 4. PREPAID EXPENSES AND OTHER CURRENT ASSETS

Prepaid
expenses and other current assets are summarized below:

SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS

|                                           |     |   |    March 
 31, 2025 |     |   | December 
 31, 2024 |
|:------------------------------------------|:----|:--|---------:|:----|:--|---------:|
| Prepaid